Amandeep Bhalla, MD
Orthopaedic Surgery · Long Beach, CANPI 1972814069
Payments from drug & device makers
What this record shows
This record is dominated by other: $1,510,026 of the $1,836,531 with a category attached, or 82.2%. Depuy Synthes Products, Inc. accounts for 82.4% of it on its own, with 33 other manufacturers making up the rest. Reporting peaked in 2022 at $1,489,990 and has fallen 99.6% since, to $5,372 in 2025. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 581 payments — averaging $3160.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Depuy Synthes Products, Inc.$1.5M
- Medical Device Business Services, Inc.$155K
- Globus Medical$76K
- Orthofix Medical, Inc.$38K
- Seaspine Orthopedics Corporation$31K
- Johnson & Johnson$8K
- plus $15K from 28 others
Across 21 payments — averaging $8282.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Orthofix Medical, Inc.$156K
- Prosidyan, Inc$18K
- Depuy Synthes Products, Inc.$800
Across 3 payments — averaging $15,238 each. An ownership or investment interest held by the physician or an immediate family member.
- Overture Orthopaedics$46K
- Prosidyan, Inc$0
What the payments were for
- Consulting fees$208,55411%
- Speaking & faculty fees$54,9903%
- Travel & lodging$37,1722%
- Food & beverage$25,7701%
- Entertainment$190%
- Other$1,510,02682%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Depuy Synthes Products, Inc. | 14 | $1,513,750 |
| Medical Device Business Services, Inc. | 80 | $155,182 |
| Globus Medical(2 entities) | 114 | $75,609 |
| Orthofix Medical, Inc. | 51 | $37,528 |
| Seaspine Orthopedics Corporation | 49 | $31,090 |
| Johnson & Johnson(2 entities) | 147 | $8,426 |
| Alphatec Spine, Inc | 20 | $3,257 |
| Medtronic(2 entities) | 30 | $2,744 |
| Kyocera Medical Technologies, Inc. | 2 | $2,000 |
| Cerapedics Inc. | 4 | $1,920 |
| Zimmer Biomet | 20 | $1,900 |
| Baxter Healthcare | 7 | $698 |
| Zimvie Inc. | 4 | $434 |
| Stryker | 4 | $396 |
| Medicrea USA, Corp. | 1 | $250 |
| Centinel Spine, LLC | 1 | $181 |
| Amgen | 1 | $174 |
| Si-bone, Inc. | 5 | $135 |
| Bioventus LLC | 4 | $116 |
| Biocomposites Inc | 1 | $108 |
| Prosidyan, Inc | 1 | $96 |
| Overture Orthopaedics | 2 | $84 |
| Innovasis Inc | 2 | $59 |
| Pfizer | 2 | $52 |
| Abbott | 2 | $51 |
| Pacira Pharmaceuticals Incorporated | 2 | $49 |
| Boston Scientific | 2 | $44 |
| Augmedics Inc. | 1 | $41 |
| Providence Medical Technology, Inc. | 3 | $36 |
| Nevro Corp. | 1 | $35 |
| Ossdsign USA Incorporated | 1 | $31 |
| Neo Spine USA, Inc. | 1 | $22 |
| Merck | 1 | $19 |
| ERMI LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPEDIUM$114,722
- Fibulink$107,697
- SYMPHONY$102,219
- CONDUIT$32,618
- ViviGen$29,395
- ELSA$18,891
- Mariner$15,420
- CREO$13,834
- Mariner MIS$12,727
- EXCELSIUS$10,908
- Regatta Lateral System$9,020
- Mariner MIS TLIF Retractor$9,020
- COALITION$8,551
- Excelsius - GPS$8,287
- RISE$7,139
- DBX$6,300
- CHRONOS$6,300
- VIPER$6,132
- Sentio$5,522
- SYNFIX Evolution$5,522
How this compares
$1,836,531 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 38 | $409 |
| Methylprednisolone | 58 | $342 |
| Gabapentin | 31 | $206 |
| Cyclobenzaprine Hcl | 21 | $192 |
| Meloxicam | 60 | $188 |
| Famotidine | 14 | $71 |
| Ibuprofen | 16 | $60 |
| Tramadol Hcl | 14 | $39 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Long Beach
- Bradford HackArcadia$18.3M
- Robert GorabOrange$13.6M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Nirav AminPlacentia$5.6M
- Tom NorrisSan Francisco$5.3M
- Jay LiebermanLos Angeles$4.8M
- Peter NewtonSan Diego$4.2M
- Sigurd BervenSan Francisco$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.